This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.
gw-chhilaen Fnigeul rsee 6ct ions in Figsuhroewss5 Haonudr 64.8F oifg au trwe o5‐dreapyr wesienndt sscHenoauriro2 a4t 2o fmth/se. Ttwheo s-ydmaybowl iXn dbys tcheen xa‐raioxisa tm8amrks/ sth, ew shoiulethFerignu ...